SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-013377
Filing Date
2020-03-27
Accepted
2020-03-27 07:25:29
Documents
100
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alt-10k_20191231.htm 10-K 3706004
2 EX-4.10 alt-ex410_379.htm EX-4.10 84741
3 EX-21 alt-ex21_6.htm EX-21 5370
4 EX-23.1 alt-ex231_10.htm EX-23.1 11177
5 EX-31.1 alt-ex311_8.htm EX-31.1 18835
6 EX-31.2 alt-ex312_9.htm EX-31.2 18568
7 EX-32.1 alt-ex321_7.htm EX-32.1 6065
8 EX-32.2 alt-ex322_11.htm EX-32.2 6052
  Complete submission text file 0001564590-20-013377.txt   12291093

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alt-20191231.xml EX-101.INS 2426612
10 XBRL TAXONOMY EXTENSION SCHEMA alt-20191231.xsd EX-101.SCH 86695
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20191231_cal.xml EX-101.CAL 88282
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20191231_def.xml EX-101.DEF 339215
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20191231_lab.xml EX-101.LAB 716288
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20191231_pre.xml EX-101.PRE 566949
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32587 | Film No.: 20748033
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences